PROTEIN BIOMARKER AND USES THEREOF

The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at a protein level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG g...

Full description

Saved in:
Bibliographic Details
Main Authors FREEMAN Daniel J, BECKMAN Robert Allen, JIN Xiaoping, YONESAKA Kimio, BLUM Sabine, MENDELL-HARARY Renee Jeanne, SCHNEIDER Matthias, NAKAGAWA Kazuhiko
Format Patent
LanguageEnglish
Published 15.06.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to methods of identifying and treating a human subject harboring a tumor or other disease comprising assessing HRG gene expression at a protein level in the human subject and administering a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at a protein level is assessed as high. The present invention is also directed to methods of identifying a human subject harboring a tumor or other disease comprising assessing HRG gene expression at a protein level in the human subject and withholding a treatment comprising an anti-HER3 antibody to the human subject whose HRG gene expression at a protein level is assessed as low. The invention is also directed to methods of performing an ELISA, including sequential steps of contacting a solid surface with a plurality of solutions each comprising in turn a capture antibody, a blocking agent, a sample suspected of containing an analyte, a detection antibody and an enzyme conjugate, in which the solid surface is subjected to a wash process after each sequential step.
Bibliography:Application Number: US201615297793